| Literature DB >> 30287941 |
Xin Wang1, Jun Gao1, Tianyu Wang1, Zhimin Li1, Yongning Li2.
Abstract
The literature discussing the long-term outcome after resection of upper cervical spinal cord tumors is limited. The purpose of this study was to review the progression-free survival (PFS), overall survival (OS), and long-term outcomes in a consecutive series of 51 patients with upper cervical spinal cord tumors who underwent surgery at our institution between 2005 and 2010. Patient outcome were evaluated using the Japanese Orthopaedic Association score (JOA) and the McCormick functional schema. Follow-up data was collected completely and the median follow-up time was 6.1 years. Gross total resection (GTR) was performed in 27 patients (52.94%) and subtotal resection (STR) in 24 patients (47.06%). Progression-free survival and overall survival at 5 years was 88.23% and 92.16%, respectively. Good prognosis was defined as 74.51% based on JOA scoring. The univariate analysis showed that patients over 60y, tumors located higher than C2, tumor size greater than 4 cm as well as malignant tumors and subtotal resection were factors indicating a poor prognosis. However, the multivariate regression analyses showed only the level of tumor and tumor size were independent risk factors for a poor prognosis. The gold standard treatment for intraspinal tumors is gross total resection and follow-up should be focused on patients with a high risk of poor prognosis.Entities:
Mesh:
Year: 2018 PMID: 30287941 PMCID: PMC6172239 DOI: 10.1038/s41598-018-33263-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Patients characteristics.
| Patient’s characteristics | Number | Percent of 51 |
|---|---|---|
| Number of patients | 51 | 100% |
|
| ||
| male | 23 | 45.10% |
| female | 28 | 54.90% |
|
| ||
| pain | 20 | 39.22% |
| numbness | 35 | 68.63% |
| muscle weakness | 27 | 52.94% |
| Gait disturbance | 9 | 17.65% |
| sphincter disturbances | 4 | 8.00% |
|
| ||
| intramedullary | 9 | 17.65% |
| extramedullary | 42 | 82.35% |
|
| ||
| Neurilemmoma | 23 | 45.10% |
| Meningioma | 6 | 11.76% |
| Neurofibroma | 6 | 11.76% |
| Ganglion cell neurofibroma | 6 | 11.76% |
| Ependymoma (WHO grade I) | 2 | 3.92% |
| Astrocytoma (WHO grade II) | 2 | 3.92% |
| Hemangioma | 3 | 5.88% |
| Teratoma | 2 | 3.92% |
| Metastatic carcinoma | 1 | 1.96% |
|
| ||
| single | 47 | 92.16% |
| Two or more | 4 | 7.84% |
| Tumor size | ||
| More than 4 cm | 12 | 23.53% |
| Less than 4 cm | 39 | 76.47% |
|
| ||
| dumbbell | 28 | 54.90% |
| non-dumbbell | 23 | 45.10% |
|
| ||
| GTR | 27 | 52.94% |
| STR | 24 | 47.06% |
|
| ||
| 100% | 16 | 31.37% |
| 60–99% | 22 | 43.14% |
| 25–59% | 6 | 11.76% |
| 0–24% | 7 | 13.73% |
|
| ||
| I | 29 | 56.86% |
| II | 12 | 23.53% |
| III | 7 | 13.73% |
| IV | 2 | 5.88% |
|
| ||
| yes | 6 | 11.76% |
| no | 45 | 88.24% |
Figure 1The distribution of tumors according to the location.
Figure 2Graph showing Kaplan-Meier estimates of progression-free survival. (green) and overall survival (blue).
preoperative and fifth year follow-up score according to the JOA.
| JOA score | |
|---|---|
|
| |
| Preoperative | 12.74 ± 2.07 |
| The fifth year follow up | 15.28 ± 2.17 |
| P value | <0.001 |
Neurological function at the preoperative and the fifth year according to the McCormick functional schema.
| Evaluation time | I | II | III | IV |
|---|---|---|---|---|
| Preoperative | 29 | 12 | 7 | 2 |
| The fifth year follow up | 37 | 7 | 3 | 0 |
Univariate analyses of variables possibly associated with prognosis.
| influence factor | The number of poor prognosis | The number of good prognosis | P value | |
|---|---|---|---|---|
| sex | male | 7 | 16 | 0.463 |
| female | 6 | 22 | ||
| age | ≥60 | 7 | 8 | 0.025 |
| <60 | 6 | 30 | ||
| The level of tumor | More than C2 | 11 | 10 | <0.001 |
| Lower than C2 | 2 | 28 | ||
| Tumor size | ≥4 cm | 8 | 2 | <0.001 |
| <4 cm | 3 | 36 | ||
| Tumor location | Intramedullary | 3 | 6 | 0.552 |
| Extramedullary | 10 | 32 | ||
| Tumor properties | Benign | 9 | 37 | 0.016 |
| malignant | 4 | 1 | ||
| surgical resection | GTR | 1 | 25 | <0.001 |
| STR | 12 | 13 | ||
| tumor multiplicity | Single | 10 | 36 | 0.185 |
| More than one | 3 | 2 | ||
| tumor morphology | dumbbell | 6 | 22 | 0.463 |
| non-dumbbell | 7 | 16 |
Multivariate regression analyses of variables possibly associated with prognosis.
| Influence factor | P value | Odds ratio (Confidence interval of 95%) |
|---|---|---|
| sex | 0.488 | 0.306 (0.011–8.684) |
| age | 0.348 | 0.175 (0.005–6.675) |
| The level of tumor | 0.044 | 0.05 (0.002–1.312) |
| Tumor size | 0.045 | 0.05 (0.002–1.331) |
| Tumor location | 0.998 | — |
| Tumor properties | 0.997 | — |
| surgical resection | 0.997 | — |
| tumor multiplicity | 0.473 | 0.186 (0.002–18.409) |
| tumor morphology | 0.998 | — |